Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Biotechnology
  Year: 2012 | Volume: 11 | Issue: 2 | Page No.: 95-99
DOI: 10.3923/biotech.2012.95.99
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Lambda Phage Nanoparticles for Targetomics

Amir Ghaemi, Alijan Tabaraei, Pooria Gill, Hoorieh Soleimanjahi and Ali Gorji

Abstract:
The emerging aim of drug delivery requires the bioactive or therapeutic molecule to be protected from degradation and reach its target cell and intracellular location. Target specificity of nanoparticles is a prerequisite to attain the concentration of therapeutic agent required for therapeutic efficacy in the target tissue while minimising adverse effects on other parts of the body. Therefore, there is an urgent need for improvement of more effective drug delivery systems to direct the anticancer drugs to cancer cells, specifically. In the paper, we have described advantages of Lambda bacteriophage over other drug delivery vectors and proposed it as promising drug delivery vehicle.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Molecular Targets in the Development of Antidiabetic Drugs
  •    pH Sensitive Drug Delivery Systems: A Review
  •    Tissue Inhibitors of Matrix Metalloproteinase-3, Potential Therapeutic Target against Multiple Sclerosis
  •    Application and Safety of Erythrocytes as a Novel Drug Delivery System
How to cite this article:

Amir Ghaemi, Alijan Tabaraei, Pooria Gill, Hoorieh Soleimanjahi and Ali Gorji, 2012. Lambda Phage Nanoparticles for Targetomics. Biotechnology, 11: 95-99.

DOI: 10.3923/biotech.2012.95.99

URL: https://scialert.net/abstract/?doi=biotech.2012.95.99

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom